Skip to main content
Premium Trial:

Request an Annual Quote

Autism Speaks to Fund Sick Kids' 700-Families Sequencing Project

NEW YORK (GenomeWeb) – Autism Speaks has awarded $800,000 to fund a study that will sequence the genomes of members of 700 Canadian families and generate data for an international genomics project focused on autism spectrum disorders.

The grant was awarded to Stephen Scherer, director of The Centre for Applied Genomics at the Hospital for Sick Children and director of the McLaughlin Centre for Molecular Medicine at the University of Toronto, to fund the ASD "Genomes to Outcomes" initiative. In this project, Scherer's lab will perform the sequencing on 700 families that are affected by autism subtypes and produce data that can be used to personalize their treatments.

Scherer's current project will aim to translate whole-genome sequencing findings and methods into the clinical setting with the goal of making earlier diagnoses, Autism Speaks said.

The results from this study will be contributed to the Autism Ten Thousand Genomes Program (AUT10K), which launched in 2011 and Scherer directs. As GenomeWeb Daily News reported in March, the AUT10K initiative reeled in a $3 million donation to fund expansion of the project into its second phase and to add more sequence data to Autism Speaks' preexisting Autism Genetic Resource Exchange.

Earlier this month, Autism Speaks said it had struck a collaboration with Google to create a database of genomic information on ASD from the AUT10K project that will be an open resource for autism researchers and will be available on the Google Cloud Platform.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.